3 ongoing Phase 3 studies are recruiting!

  1. A randomized Phase 3 Study is now recruiting patients who are:

    • Unresectable, locally advanced or metastatic NSCLC

    • KRAS G12C mutation

    • Disease progression on or after treatment with platinum-based regimen and an immune checkpoint inhibitor.

  2. A randomized Phase 3 Study is now recruiting patients who are:

    • Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    • Treatment Naïve

    • PD-L1 >=50%

  3. A randomized Phase 3 Study is now recruiting patients who are :

  • Locally advanced, unresectable, metastatic Gastrointestinal stromal tumors

  • Treatment experienced with imatinib

If you are interested to be a participant, please contact us!